Biosafety Administrators 201 and Best Practices Meeting

 Registration is closed for this event

Meeting Objective

The objective of each meeting  is to provide meeting attendees a wealth of information, and most importantly the opportunity to develop professional relationships with one another through engaging conversations (i.e., ideas provided by our members). During the meeting, specific topics will be analyzed by meeting facilitators and attendees to identify points of concern, answer questions, and refine practices that can be used to achieve desired goals.

The IBC 201/Best Practice meeting is a 5-hour training opportunity for both new and seasoned Biosafety committee members, Biosafety Administrators, program compliance coordinators, and other individuals who contribute to the institution’s biosafety compliance program. Sessions are initiated using didactic presentations that are intended to provide sufficient background on a number of topics to ensure attendees have a general understanding of an overall Institutional Biosafety programs. During each meeting session it is important for attendees to engage in the discussion should any questions arise. Attendees are encouraged to submit ( questions PRIOR TO the meeting and may be encouraged to interact by discussing their own institutions practices.

Programs Support

The Biosafety Administrator Association (BSAA) meetings and related activities are supported through BSAA memberships and event attendance fees.  To reduce your attendance fees at BSAA upcoming meetings, we ask that you please become a new member or maintain your current membership status (memberships are renewed annually). If you are a current member of the BSAA, you may attend the IBC 201 program at the reduced rate of $235. Individuals that are non-members or those with expired memberships are asked to provide $335 in support for each meeting they attend. Please confirm your active membership status at the following link (Current Membership?) prior to registering for this event.

Topics Summary

The tentative meeting schedule is as follows:


Welcome, Opening Remarks and Introductions


Institutional Biosafety Programs (BP):


    1. Demographics discussion: how have BPs developed
    2. Understanding when to and how specific regulatory standards are applied. 


BP Governance:

    1. Typical BP policies, guidelines, and SOPs with focus the scope of the IBC
    2. Program leadership, peers, and individual roles.
    3. The IBC Charter, some sample ideas and relevant discussions.




    1. The IBC membership and its role
    2. Techniques for developing the IBC agenda and running the meeting.
    3. Meeting minutes: what must be included and excerpts from approved minutes.


Managing IBC Reviews/Registrations

    1. Identifying what section of the NIH Guidelines research is subject to (flowcharts)
    2. Types of registration reviews that can be used by the IBC.




Protocol Form and Review Process

    1. Analyzing a sample template review form
    2. Reviewing the protocol: risk assessment and confinement expectations


Program Oversight

    1. Performing a regulatory review of your BP – a practical process will be identified.
    2. Compliance management – techniques to for the IBC to oversee the BP
    3. Disaster and Incident management program – scenario discussion

Presenter(s) Biographies

Bill Greer, Assistant Vice President for Research, University of Michigan

Bill graduated from The Pennsylvania State University in 1985 with a degree in Microbiology.  He currently oversees the animal care and use, biosafety, lab safety, controlled substances, and autonomous systems research compliance programs.  His previous roles included the Associate Director for Research Compliance, IACUC Vice-Chair, and Biosafety Committee Chair at The Pennsylvania State University, and the production manager and safety director at Intervet, State College, PA (Formally Tri Bio Laboratories). Bill has overseen animal care and biosafety programs for over 30 years. 

In 2005, he organized and held the very first research administrators Best Practice Meeting, which establish a venue for research oversight professionals to informally meet and discuss programmatic concerns.  He continues to facilitate at least five annual Best Practice meetings covering both biosafety and animal care and use programs.  In 2010, he chaired the founding committee for the non-profit education based IACUC Administrators Association (IAA), and continues to serve as the organization’s president and chair of the board of directors.  Since 2007, Bill has served as ad hoc consultant to AAALAC Council where he performs institutional program reviews, assessments, and status determinations.  He served as a member of the Council of Certified Professional IACUC Administrators (CCPIA).  Bill continues to serve as an educator for the IBC and IACUC Administrative communities and has lectures at multiple venues including PRIM&R, AALAS, BTAA, and C3, as well as facilitates IBC and IACUC Best Practice Meetings.

Jonah Lee, BS, MS, PhD:

As the Associate Director for the Animal Care & Use Office (ACUO), Dr. Lee brings experience and a proven track record in the biomedical sciences and academic research administration to provide thought leadership, program oversight, and process optimization with specific attention to researcher/user-experience coordination across the Animal Care & Use Program.

In collaboration with other U-M research administrative departments and academic department leadership, Dr. Lee is charged with the strategic development of research engagement infrastructure and resource support.


  • PhD (Human Bioenergetics), Ball State University
  • MS (Pediatric Exercise Science), Ball State University
  • BS (Human Physiology), University of Oregon

Dr. Lee has an extensive background in the life sciences, where his research focus involves stem cell biology and regenerative medicine in aging skeletal muscle. Along with his postdoctoral research at the Center for Muscle Biology at the University of Kentucky, and his work at U-M, his animal research experience includes considerable diversity in both small and large animal models across multi-departmental, federally-funded research projects. 

Andrew Maksymowych, Ph.D., Associate Director, Biosafety Programs

Andrew has been at the University of Pennsylvania since 2006.  He is Penn’s Associate Director for Biological Safety Programs, Penn’s Institutional Biosafety Officer, IBC Administrator, and the Institutional Contact for Dual Use Research.  He sits on the Vice Provost’s for Research, Human Research Advisory Committee, the Human Stem Cell Research Advisory Committee, and the Cadaver and Body Parts Oversight Committee.  Andrew obtained his B.S. and M.S. degrees from Villanova University, and his Ph.D. in Biochemistry from Bryn Mawr College.  He has more than 20 years of teaching and 35 years of research experience.  A major portion of which included oversight of research safety and compliance programs.  Prior to his journey at Penn, he held a faculty appointment at Thomas Jefferson University where his research focused on the analysis of structure-function relationships in proteins, including protein toxins that poison the human nervous system.  Most recently, the mechanism of action of botulinum neurotoxins.  Andrew attended his first Best Practice Meeting in 2015 and has since been continually involved with Biosafety Administrator’s Association.

Raymond F. Scheetz, MS, RBP is currently the Institutional Biosafety Officer and a Compliance Manager at The Penn State University College of Medicine in Hershey, Pa, located in the Research Quality Assurance office a division of the College of Medicine Office of Research Affairs.  He is responsible for the oversight of all Biosafety compliance aspects within the College of Medicine, providing ancillary reviews of IACUC and IRB protocols, biosafety training and required annual lab surveys, administration liaison for research lab activities and emergencies, and operation of the equipment and asset management plan. He is a member of the College of Medicine Institutional Biosafety Committee, Research Mission team and COVID 19 Ramp up Research task force.  Ray also serves as a Biosafety consultant for CBS (Clinical Biosafety Services)/Shield Consulting.  Formally the Lab Manager in the Department of Microbiology and Immunology at the Penn State College of Medicine for 25 years.  Responsibilities included the Management of the BL3 facility located within the Department.

June 6th, 2024 from 11:30 AM to  4:30 PM
virtual Meeting
Event Fee(s)
Non-Member's Attendance Fee $335.00
Member's Attendance Fee $235.00